Intriguingly, RVD-Hp administration counteracts the anxiety- and depressive-like behaviors induced by hemopressin [9,10], suggesting a potential blockade of the TRPV1 channel by RVD-Hp. The gene discussed is TRPV1; the disease is Anxiety.